Shu-Min Lin, MD

Chang Gung Memorial Hospital, Taiwan

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-792) Evaluation of the efficacy and safety of a short-course, daily, 4-month regimen including isoniazid, pyrazinamide, rifapentine and moxifloxacin (2HZPM/2HPM) for the treatment of drug-susceptible pulmonary tuberculosis in Taiwan (ESCAPE-TB): A multicenter study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT